PAVmed (PAVM) Income towards Parent Company (2016 - 2026)

PAVmed has reported Income towards Parent Company for 11 years, with the latest figure at -$6.6 million in Q2 2026.

• On a quarterly basis, Income towards Parent Company rose 46.46% year-over-year to -$6.6 million in Q2 2026; TTM through Jun 2026 was -$27.7 million, a 270.53% decrease from a year earlier, with the FY2025 full-year figure at -$2.0 million, down 106.86% from the prior year.
• Income towards Parent Company was -$6.6 million for Q2 2026 at PAVmed, down from -$2.8 million in the prior quarter.
• The five-year high for Income towards Parent Company was $18.6 million in Q1 2025, with the low at -$29.9 million in Q3 2022.
• Average Income towards Parent Company over 5 years is -$14.0 million, with a median of -$17.6 million recorded in 2023.
• The largest YoY upside for Income towards Parent Company was 200.6% in 2025 against a maximum downside of 341.42% in 2025.
• Over 5 years, Income towards Parent Company stood at -$24.6 million in 2022, then grew by 29.16% to -$17.4 million in 2023, then soared by 106.56% to $1.1 million in 2024, then slumped by 341.42% to -$2.8 million in 2025, then plunged by 139.32% to -$6.6 million in 2026.
• The last three Income towards Parent Company figures came in at -$6.6 million (Q2 2026), -$2.8 million (Q4 2025), and -$6.0 million (Q3 2025), per Business Quant data.